Time to rewrite AIDS vaccine playbook

The head of the International AIDS Vaccine Initiative, Seth Berkley, wants to rewrite the playbook for developing an effective AIDS vaccine. Out: The disastrous Merck approach to spur cell-based immunity. In: Recruiting antibodies to neutralize the virus. The Wall Street Journal notes that four antibodies have been identified by a research consortium as potentially up to the task while Berkley believes the list could be as high as 15. Report

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.